Compare LACTOSE INDIA with ZENITH HEALTH - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs ZENITH HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA ZENITH HEALTH LACTOSE INDIA/
ZENITH HEALTH
 
P/E (TTM) x -135.6 151.9 - View Chart
P/BV x 2.1 8.7 24.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LACTOSE INDIA   ZENITH HEALTH
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
ZENITH HEALTH
Mar-21
LACTOSE INDIA/
ZENITH HEALTH
5-Yr Chart
Click to enlarge
High Rs4215 271.5%   
Low Rs161 1,797.8%   
Sales per share (Unadj.) Rs30.62.6 1,195.3%  
Earnings per share (Unadj.) Rs-2.20.1 -2,645.6%  
Cash flow per share (Unadj.) Rs1.60.1 1,280.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs30.11.3 2,367.0%  
Shares outstanding (eoy) m11.4453.74 21.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.93.2 29.7%   
Avg P/E ratio x-13.399.4 -13.4%  
P/CF ratio (eoy) x17.663.3 27.7%  
Price / Book Value ratio x1.06.4 15.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m330437 75.5%   
No. of employees `000NANA-   
Total wages/salary Rs m10611 1,008.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m350137 254.5%  
Other income Rs m35 68.0%   
Total revenues Rs m353142 248.4%   
Gross profit Rs m624 1,733.4%  
Depreciation Rs m443 1,743.2%   
Interest Rs m540 49,527.3%   
Profit before tax Rs m-336 -586.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-81 -672.0%   
Profit after tax Rs m-254 -563.2%  
Gross profit margin %17.82.6 680.7%  
Effective tax rate %24.221.2 114.5%   
Net profit margin %-7.13.2 -221.3%  
BALANCE SHEET DATA
Current assets Rs m19764 308.7%   
Current liabilities Rs m11619 604.3%   
Net working cap to sales %23.132.4 71.2%  
Current ratio x1.73.3 51.1%  
Inventory Days Days597 839.9%  
Debtors Days Days67144,857,990 0.0%  
Net fixed assets Rs m68621 3,328.9%   
Share capital Rs m11454 212.8%   
"Free" reserves Rs m23015 1,567.9%   
Net worth Rs m34568 503.9%   
Long term debt Rs m3930-   
Total assets Rs m88384 1,046.2%  
Interest coverage x0.451.7 0.8%   
Debt to equity ratio x1.10-  
Sales to assets ratio x0.41.6 24.3%   
Return on assets %3.45.3 62.9%  
Return on equity %-7.26.4 -111.8%  
Return on capital %3.08.3 35.5%  
Exports to sales %00-   
Imports to sales %7.40-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m26NA-   
Fx inflow Rs m2573 33.7%   
Fx outflow Rs m271 2,316.5%   
Net fx Rs m-272 -2.9%   
CASH FLOW
From Operations Rs m22-15 -147.8%  
From Investments Rs m-62-2 3,320.4%  
From Financial Activity Rs m45NA-  
Net Cashflow Rs m5-17 -31.0%  

Share Holding

Indian Promoters % 49.1 28.7 170.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.7 0.4 174.4%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.9 71.3 71.4%  
Shareholders   15,737 28,995 54.3%  
Pledged promoter(s) holding % 47.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Jubilant FoodWorks' Stock Split, Delhivery's Rs 76.4 bn IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a flat note on Friday. Benchmark indices snapped their four-day winning run and ended lower amid weak global cues.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

My Best Sectors for 2022(Fast Profits Daily)

Jan 4, 2022

My top 2 sectors for 2022 might surprise you.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Jan 14, 2022 (Close)

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA 5-YR ANALYSIS

COMPARE LACTOSE INDIA WITH

MARKET STATS